You are here: Industry Insights > AAV

News List

Sanofi partners with SIRION to improve AAV capsids for gene therapy treatments pharmatimes
February 25, 2021
SIRION Biotech has signed a license and collaboration with Sanofi to develop improved adeno-associated virus capsids for gene therapy treatments for disorders affecting major human organs.
Neurophth Closes RMB 400 Million Series B Financing prnasia
February 10, 2021
Neurophth Biotechnology Ltd. announced the closing of a RMB 400 million ($61.9 million USD) Series-B financing with a premier syndicate of investors, co-led by Guofang Capital and InnoVision Capital.
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy prnasia
January 19, 2021
Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELPTM platform to develop next-generation gene therapies.
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy prnasia
January 19, 2021
Neurophth Therapeutics, Inc. and AAVnerGene Inc. today announced a strategic partnership to provide Neurophth with worldwide rights to mutually select adeno-associated virus (AAV) capsids for the next generation ophthalmic gene therapy.
Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline pharmaceutical-business-review
January 14, 2021
Rocket Pharmaceuticals, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces the Company’s plans for the buildout of its new Research and Development (R&D) and Chemistry ...
Sarepta and Dyno Therapeutics Will Develop Next-Gen Gene Therapy Vectors contractpharma
May 13, 2020
Dyno’s proprietary CapsidMap platform opens up new ways to identify novel capsids.
Lonza Launches TheraPEAK SfAAV Medium contractpharma
March 24, 2020
Designed specifically for production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells for gene therapy applications.
AskBio Enters Research Collaboration with UNC contractpharma
March 19, 2020
Collaboration builds upon preclinical research that demonstrates potential for gene therapy to correct deficiency in UBE3A gene.
AskBio Acquires Synpromics Ltd. contractpharma
August 15, 2019
The two companies bring together pioneering technology to increase efficacy of gene therapeutics.
Amicus, Brammer Bio Enter Gene Therapy Devt. and Mfg. Collaboration contractpharma
July 02, 2019
Supports clinical and commercial supply needs for multiple batten disease programs.

Previous page 1 2 3 4 Next page